Hind D - Search Results

1

Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma: systematic review and economic evaluation.

Knight C, Hind D, Brewer N, Abbott V. Knight C, et al. Among authors: hind d. Health Technol Assess. 2004 Sep;8(37):iii, ix-xi, 1-82. doi: 10.3310/hta8370. Health Technol Assess. 2004. PMID: 15361313 Free article. Review.

2

The effectiveness and cost-effectiveness of ultrasound locating devices for central venous access: a systematic review and economic evaluation.

Calvert N, Hind D, McWilliams RG, Thomas SM, Beverley C, Davidson A. Calvert N, et al. Among authors: hind d. Health Technol Assess. 2003;7(12):1-84. doi: 10.3310/hta7120. Health Technol Assess. 2003. PMID: 12709290 Free article. Review. No abstract available.

3

Ultrasound for central venous cannulation: economic evaluation of cost-effectiveness.

Calvert N, Hind D, McWilliams R, Davidson A, Beverley CA, Thomas SM. Calvert N, et al. Among authors: hind d. Anaesthesia. 2004 Nov;59(11):1116-20. doi: 10.1111/j.1365-2044.2004.03906.x. Anaesthesia. 2004. PMID: 15479322 Free article. Review.

4

Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies.

Greenhalgh J, Knight C, Hind D, Beverley C, Walters S. Greenhalgh J, et al. Among authors: hind d. Health Technol Assess. 2005 Mar;9(9):1-156, iii-iv. doi: 10.3310/hta9090. Health Technol Assess. 2005. PMID: 15774232 Free article. Review.

5

Economic analysis of the implementation of autologous transfusion technologies throughout England.

Dixon S, James V, Hind D, Currie CJ. Dixon S, et al. Among authors: hind d. Int J Technol Assess Health Care. 2005 Spring;21(2):234-9. Int J Technol Assess Health Care. 2005. PMID: 15921064 Free article.

6

Methodological issues in the economic analysis of cancer treatments.

Tappenden P, Chilcott J, Ward S, Eggington S, Hind D, Hummel S. Tappenden P, et al. Among authors: hind d. Eur J Cancer. 2006 Nov;42(17):2867-75. doi: 10.1016/j.ejca.2006.08.010. Epub 2006 Oct 4. Eur J Cancer. 2006. PMID: 17023160 Review.

7

Hormonal therapies for early breast cancer: systematic review and economic evaluation.

Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld L. Hind D, et al. Health Technol Assess. 2007 Jul;11(26):iii-iv, ix-xi, 1-134. doi: 10.3310/hta11260. Health Technol Assess. 2007. PMID: 17610808 Free article. Review.

8

Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation.

Ward S, Simpson E, Davis S, Hind D, Rees A, Wilkinson A. Ward S, et al. Among authors: hind d. Health Technol Assess. 2007 Oct;11(40):1-144. doi: 10.3310/hta11400. Health Technol Assess. 2007. PMID: 17903394 Free article. Review.

9

The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.

Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A. Hind D, et al. Health Technol Assess. 2008 May;12(15):iii-ix, xi-162. doi: 10.3310/hta12150. Health Technol Assess. 2008. PMID: 18462574 Free article. Review.

10

Trastuzumab for the treatment of primary breast cancer in HER2-positive women: a single technology appraisal.

Ward S, Pilgrim H, Hind D. Ward S, et al. Among authors: hind d. Health Technol Assess. 2009 Jun;13 Suppl 1:1-6. doi: 10.3310/hta13suppl1/01. Health Technol Assess. 2009. PMID: 19567207 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters